Nathalie Hirt-Burri

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


77 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2001 | 1999 | 1997 |
2024
A New Ex Vivo Human Skin Burn Model.
Labouchère A., Haselbach D., Michetti M., Pythoud C., Raffoul W., Applegate L.A., Hirt-Burri N., de Buys Roessingh A., 2024/03/04. Journal of burn care & research, 45 (2) pp. 308-317. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30CD00DA73AB]
2023
Ex Vivo Functional Benchmarking of Hyaluronan-Based Osteoarthritis Viscosupplement Products: Comprehensive Assessment of Rheological, Lubricative, Adhesive, and Stability Attributes.
Porcello A., Hadjab F., Ajouaou M., Philippe V., Martin R., Abdel-Sayed P., Hirt-Burri N., Scaletta C., Raffoul W., Applegate L.A. et al., 2023/10/09. Gels, 9 (10) p. 808. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C10A7BF26F8E]
Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification.
Philippe V., Jeannerat A., Peneveyre C., Jaccoud S., Scaletta C., Hirt-Burri N., Abdel-Sayed P., Raffoul W., Darwiche S., Applegate L.A. et al., 2023/09/16. Pharmaceutics, 15 (9) p. 2333. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C0D748D22C56]
 
Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care.
Chen X., Laurent A., Liao Z., Jaccoud S., Abdel-Sayed P., Flahaut M., Scaletta C., Raffoul W., Applegate L.A., Hirt-Burri N., 2023/09/16. Pharmaceutics, 15 (9) p. 2334. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9797A6B9E5DD]
Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes: Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine.
Jeannerat A., Meuli J., Peneveyre C., Jaccoud S., Chemali M., Thomas A., Liao Z., Abdel-Sayed P., Scaletta C., Hirt-Burri N. et al., 2023/07/03. Pharmaceutics, 15 (7) p. 1873. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E77B0FEB830]
 
Thermo-Responsive Hyaluronan-Based Hydrogels Combined with Allogeneic Cytotherapeutics for the Treatment of Osteoarthritis.
Porcello A., Gonzalez-Fernandez P., Jeannerat A., Peneveyre C., Abdel-Sayed P., Scaletta C., Raffoul W., Hirt-Burri N., Applegate L.A., Allémann E. et al., 2023/05/18. Pharmaceutics, 15 (5) p. 1528. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B21831AB42DC]
 
Process Optimization and Efficacy Assessment of Standardized PRP for Tendinopathies in Sports Medicine: Retrospective Study of Clinical Files and GMP Manufacturing Records in a Swiss University Hospital.
Sebbagh P., Hirt-Burri N., Scaletta C., Abdel-Sayed P., Raffoul W., Gremeaux V., Laurent A., Applegate L.A., Gremion G., 2023/03/25. Bioengineering, 10 (4) p. 409. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E069875488C1]
Primary Progenitor Tenocytes: Cytotherapeutics and Cell-Free Derivatives
Laurent Alexis, Scaletta Corinne, Abdel-Sayed Philippe, Raffoul Wassim, Hirt-Burri Nathalie, Applegate Lee Ann, 2023/03/16. Encyclopedia, 3 (1) pp. 340-361.
[URN][DOI][serval:BIB_3A4195A8BE38]
 
Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine.
Sebbagh P., Cannone A., Gremion G., Gremeaux V., Raffoul W., Hirt-Burri N., Michetti M., Abdel-Sayed P., Laurent A., Wardé N. et al., 2023/02/24. Bioengineering, 10 (3) p. 292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_272C3A91FB7F]
Industrial Biotechnology Conservation Processes: Similarities with Natural Long-Term Preservation of Biological Organisms.
Laurent A., Scaletta C., Abdel-Sayed P., Raffoul W., Hirt-Burri N., Applegate L.A., 2023/01/31. Biotech, 12 (1) p. 15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2479CFE45C72]
Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects.
Laurent A., Porcello A., Jeannerat A., Peneveyre C., Coeur A., Abdel-Sayed P., Scaletta C., Michetti M., de Buys Roessingh A., Jordan O. et al., 2023/01/10. Antioxidants, 12 (1) p. 163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B3E4B5B2BB84]
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care.
Laurent A., Rey M., Scaletta C., Abdel-Sayed P., Michetti M., Flahaut M., Raffoul W., de Buys Roessingh A., Hirt-Burri N., Applegate L.A., 2023/01/04. Pharmaceutics, 15 (1) p. 184. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_543C281B1D65]
2022
 
Hyaluronan-Based Hydrogels as Functional Vectors for Standardised Therapeutics in Tissue Engineering and Regenerative Medicine
Porcello Alexandre, Laurent Alexis, Hirt-Burri Nathalie, Abdel-Sayed Philippe, de Buys Roessingh Anthony, Raffoul Wassim, Jordan Olivier, Allémann Eric, Applegate Lee Ann, 2022/03/29. pp. 119-148 dans Nanopharmaceuticals in Regenerative Medicine, CRC Press.
[DOI][serval:BIB_169632AE91A9]
Retrospective Analysis of Autologous Chondrocyte-Based Cytotherapy Production for Clinical Use: GMP Process-Based Manufacturing Optimization in a Swiss University Hospital.
Philippe V., Laurent A., Hirt-Burri N., Abdel-Sayed P., Scaletta C., Schneebeli V., Michetti M., Brunet J.F., Applegate L.A., Martin R., 2022/03/17. Cells, 11 (6) p. 1016. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FDC192E178F4]
 
Biotechnology and Cytotherapeutics: The Swiss Progenitor-Cell Transplantation Program
Laurent Alexis, Scaletta Corinne, Abdel-Sayed Philippe, Michetti Murielle, de Buys Roessingh Anthony, Raffoul Wassim, Hirt-Burri Nathalie, Applegate Lee Ann, 2022/01/30. Encyclopedia, 2 (1) pp. 336-364.
[DOI][serval:BIB_C48CB1FFEEE7]
2021
Combination of Hyaluronan and Lyophilized Progenitor Cell Derivatives: Stabilization of Functional Hydrogel Products for Therapeutic Management of Tendinous Tissue Disorders.
Laurent A., Porcello A., Fernandez P.G., Jeannerat A., Peneveyre C., Abdel-Sayed P., Scaletta C., Hirt-Burri N., Michetti M., de Buys Roessingh A. et al., 2021/12/19. Pharmaceutics, 13 (12) p. 2196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DBCEF906F288]
Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland.
Laurent A., Abdel-Sayed P., Scaletta C., Laurent P., Laurent E., Michetti M., de Buys Roessingh A., Raffoul W., Hirt-Burri N., Applegate L.A., 2021/12/17. Bioengineering, 8 (12) p. 221. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3E261CA71905]
Human Platelet Lysate as an Alternative to Autologous Serum for Human Chondrocyte Clinical Use.
Philippe V., Laurent A., Abdel-Sayed P., Hirt-Burri N., Ann Applegate L., Martin R., 2021/12. Cartilage, 13 (1_suppl) pp. 509S-518S. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_72C79A8BAF5C]
Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine.
Jeannerat A., Peneveyre C., Armand F., Chiappe D., Hamelin R., Scaletta C., Hirt-Burri N., de Buys Roessingh A., Raffoul W., Applegate L.A. et al., 2021/10/25. Cells, 10 (11) p. 2872. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8B15556E47DA]
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
Chemali M., Laurent A., Scaletta C., Waselle L., Simon J.P., Michetti M., Brunet J.F., Flahaut M., Hirt-Burri N., Raffoul W. et al., 2021/09/30. Journal of burn care & research, 42 (5) pp. 911-924. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2FE665354651]
Corrigendum to: Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
Chemali M., Laurent A., Scaletta C., Waselle L., Simon J.P., Michetti M., Brunet J.F., Flahaut M., Hirt-Burri N., Raffoul W. et al., 2021/09/30..
[URN][DOI][WoS][Pmid][serval:BIB_5E6F00556428]
 
Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine.
Laurent A., Abdel-Sayed P., Hirt-Burri N., Scaletta C., Michetti M., de Buys Roessingh A., Raffoul W., Applegate L.A., 2021/09/24. Cells, 10 (10) p. 2526. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A4B102DBA12]
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine.
Laurent A., Scaletta C., Abdel-Sayed P., Michetti M., Flahaut M., Simon J.P., Roessingh A.B., Raffoul W., Hirt-Burri N., Applegate L.A., 2021/08/23. Biomedicines, 9 (8) p. 1072. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C8CFF2F5FAC]
 
Bonnes Pratiques de Fabrication et thérapies cellulaires au chevet des grands brûlés romands
Laurent Alexis, Abdel-Sayed Philippe, Chemale Michèle, Hirt-Burri Nathalie, Raffoul Wassim, Applegate Lee Ann, de Buys Roesingh Anthony S, 2021/07/01. PharmaJournal Suisse, 2021 (6/7) pp. 10-14.
[serval:BIB_06210850C49D]
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care
Al-Dourobi Karim, Laurent Alexis, Deghayli Lina, Flahaut Marjorie, Abdel-Sayed Philippe, Scaletta Corinne, Michetti Murielle, Waselle Laurent, Simon Jeanne-Pascale, El Ezzi Oumama et al., 2021/02/28. Pharmaceuticals, 14 (3) p. 201.
[URN][DOI][WoS][Pmid][serval:BIB_5D7C504E9636]
 
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.
Al-Dourobi K., Laurent A., Deghayli L., Flahaut M., Abdel-Sayed P., Scaletta C., Michetti M., Waselle L., Simon J.P., Ezzi O.E. et al., 2021/02/28. Pharmaceuticals, 14 (3) p. 201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FFCCB34FEBF6]
Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation.
Laurent A., Abdel-Sayed P., Ducrot A., Hirt-Burri N., Scaletta C., Jaccoud S., Nuss K., Roessingh ASB, Raffoul W., Pioletti D. et al., 2021/02/09. Biomolecules, 11 (2) p. 250. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4DA1AC43247]
 
GMP Tiered Cell Banking of Non-enzymatically Isolated Dermal Progenitor Fibroblasts for Allogenic Regenerative Medicine.
Laurent A., Scaletta C., Michetti M., Hirt-Burri N., de Buys Roessingh A.S., Raffoul W., Applegate L.A., 2021. Methods in molecular biology, 2286 pp. 25-48. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_66D94F68D9E8]
 
Progenitor Biological Bandages: An Authentic Swiss Tool for Safe Therapeutic Management of Burns, Ulcers, and Donor Site Grafts.
Laurent A., Scaletta C., Michetti M., Hirt-Burri N., Flahaut M., Raffoul W., de Buys Roessingh A.S., Applegate L.A., 2021. pp. 49-65 dans Stem Cells and Good Manufacturing Practices, Springer.
[DOI][WoS][Pmid][serval:BIB_35D2A0A1B41E]
 
Swiss Fetal Transplantation Program and Non-enzymatically Isolated Primary Progenitor Cell Types for Regenerative Medicine.
Laurent A., Scaletta C., Hirt-Burri N., Raffoul W., de Buys Roessingh A.S., Applegate L.A., 2021. Methods in molecular biology, 2286 pp. 1-24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8895EE5EA322]
2020
Implications of chlorhexidine use in burn units for wound healing.
Abdel-Sayed P., Tornay D., Hirt-Burri N., de Buys Roessingh A., Raffoul W., Applegate L.A., 2020/08. Burns, 46 (5) pp. 1150-1156. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF527DF952BE]
 
Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds
Laurent Alexis, Lin Poyin, Scaletta Corinne, Hirt-Burri Nathalie, Michetti Murielle, de Buys Roessingh Anthony S., Raffoul Wassim, She Bin-Ru, Applegate Lee Ann, 2020/06/19. Frontiers in Bioengineering and Biotechnology, 8 p. 581.
[URN][DOI][Pmid][serval:BIB_174411BEC208]
 
Reply to the Letter to the Editor on "The use of antiseptics in burn wounds - our perspective".
Abdel-Sayed P., Tornay D., Hirt-Burri N., de Buys Roessingh A., Raffoul W., Applegate L.A., 2020/06. Burns, 46 (4) pp. 981-982. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D10407241EE1]
 
Banking Progenitor Cells for Hippiatric Regenerative Medicine: Optimized Establishment of Safe and Consistent Cell Sources for Standardized Veterinary Therapeutic Protocols
Laurent Alexis, Darwiche Salim, Hirt-Burri Nathalie, Scaletta Corinne, Michetti Murielle, Laurent Philippe, Raffoul Wassim, Buys Roessingh Anthony S de, Applegate Lee Ann, 2020/04/13. American Journal of Biomedical Science & Research, 8 (4).
[DOI][serval:BIB_B0F2098AA2F3]
Efficient decellularization of equine tendon with preserved biomechanical properties and cytocompatibility for human tendon surgery indications.
Aeberhard P.A., Grognuz A., Peneveyre C., McCallin S., Hirt-Burri N., Antons J., Pioletti D., Raffoul W., Applegate L.A., 2020/04. Artificial organs, 44 (4) pp. E161-E171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1334F6D4BC95]
 
Primary Progenitor Muscle Cells for Regenerative Medicine: Standardization of Therapeutic Protocols and Optimized In Vivo Murine Model For Volumetric Muscle Loss
Laurent Alexis, Hirt-Burri Nathalie, Amiot Clotilde, Scaletta Corinne, Applegate Lee Ann, Buys Roessingh Anthony S de, 2020/03/19. American Journal of Biomedical Science & Research, 8 (2) pp. 143-153.
[URN][DOI][serval:BIB_1F0BEA8F6038]
 
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology.
Laurent A., Hirt-Burri N., Scaletta C., Michetti M., de Buys Roessingh A.S., Raffoul W., Applegate L.A., 2020. Frontiers in bioengineering and biotechnology, 8 p. 557758. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B14FB5241E5E]
 
Progenitor Biological Bandages: An Authentic Swiss Tool for Safe Therapeutic Management of Burns, Ulcers, and Donor Site Grafts
Laurent Alexis, Scaletta Corinne, Michetti Murielle, Hirt-Burri Nathalie, Flahaut Marjorie, Raffoul Wassim, de Buys Roessingh Anthony S., Applegate Lee Ann, 2020. Methods in Molecular Biology.
[DOI][Pmid][serval:BIB_2D7B265163B4]
Surgical Management Evolution Between 2 Massive Burn Cases at 17-Year Interval: Contribution of Cell Therapies in Improving the Surgical Care.
Monnier S., Abdel-Sayed P., Roessingh A.B., Hirt-Burri N., Chemali M., Applegate L.A., Raffoul W., 2020. Cell transplantation, 29 p. 963689720973642. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1F193A6A252]
2019
Evolution of Biological Bandages as First Cover for Burn Patients.
Abdel-Sayed P., Hirt-Burri N., de Buys Roessingh A., Raffoul W., Applegate L.A., 2019/11/01. Advances in wound care, 8 (11) pp. 555-564. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC7604AFE085]
 
Acceptation of Folk Medicine and its "secrets" in a Swiss Burn Centre.
Kasser S., Applegate L.A., Hirt-Burri N., Jafari P., de Buys Roessingh A., Raffoul W., Berger M.M., 2019/09/30. Annals of burns and fire disasters, 32 (3) pp. 227-233. Peer-reviewed.
[Pmid][serval:BIB_6F1E388420AF]
 
Potency and stability of liposomal Amphotericin B formulated for topical management of Aspergillus spp. infections in burn patients
Laurent Alexis, Pantet Olivier, Laurent Lydie, Hirt-Burri Nathalie, de Buys Roessingh Anthony, Raffoul Wassim, Laurent Philippe, Monod Michel, Ann Applegate Lee, 2019/09. Burns Open.
[DOI][serval:BIB_C22B8C00946F]
 
Foetal cell Therapy in Treatment of Burns and Wounds
Applegate Lee Ann, de Buys Roessingh Anthony, Raffoul Wassim, Hirt-Burri Nathalie, 2019/07/23. dans Comprehensive Biotechnology 3rd edition , Elsevier Science & Technology, 2019.
[DOI][serval:BIB_103018646106]
Cell therapies for skin regeneration: an overview of 40 years of experience in burn units.
Abdel-Sayed P., Michetti M., Scaletta C., Flahaut M., Hirt-Burri N., de Buys Roessingh A., Raffoul W., Applegate L.A., 2019/05/06. Swiss medical weekly, 149 pp. w20079. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63158D24E889]
 
Cell Therapies for Tendon: Treatments and Regenerative Medicine
Grognuz Anthony, Aeberhard Pierre-Arnaud, Michetti Murielle, Hirt-Burri Nathalie, Scaletta Corinne, de Buys Roessingh Anthony, Raffoul Wassim, Applegate Lee Ann, 2019. pp. 385-408 dans Regenerative Medicine and Plastic Surgery, Springer International Publishing.
[DOI][serval:BIB_78D5706A1563]
2018
Patient care for postamputation pain and the complexity of therapies: living experiences.
Flahaut M., Laurent N.L., Michetti M., Hirt-Burri N., Jensen W., Lontis R., Applegate L.A., Raffoul W., 2018/11/01. Pain management, 8 (6) pp. 441-453. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C143D09A42E]
Decellularised tissues obtained by a CO2-philic detergent and supercritical CO2
Antons J, Marascio MGM, Aeberhard P, Weissenberger G, Hirt-Burri N, Applegate LA, Bourban PE, Pioletti DP, 2018/09/04. European Cells and Materials, 36 pp. 81-95.
[URN][DOI][WoS][Pmid][serval:BIB_ED2B5FEDB00E]
Polycyclic aromatic hydrocarbons (PAHs) skin permeation rates change with simultaneous exposures to solar ultraviolet radiation (UV-S).
Hopf Nancy B., Spring Philipp, Hirt-Burri Nathalie, Jimenez Silvia, Sutter Benjamin, Vernez David, Berthet Aurélie, 2018/05/01. Toxicology Letters, 287 pp. 122-130. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_749CE9A9840F]
2017
 
Alternatives for Dermal Toxicity Testing
Appelgate Lee Ann, Jafari Paris, Scaletta Corinne, de Buys Roessingh Anthony, Raffoul Wassim, Hirt-Buri Nathalie, 2017. pp. 547-562 dans Ch. 40 "Progrenitor Skin Cell Therapy and Evolution of Medical Applications" chap. 40, Springer International Publishing.
[DOI][serval:BIB_5B0EAEF0BA27]
 
Progenitor Skin Cell Therapy and Evolution of Medical Applications
Jafari Paris, Scaletta Corinne, De Buys Roessingh Anthony, Raffoul Wassim, Hirt-Burri Nathalie, 2017. dans Alternatives for Dermal Toxicity Testing , Springer International Publishing.
[DOI][serval:BIB_5C6AAD5E1A85]
2016
Burn patient care lost in good manufacturing practices?
Dimitropoulos G., Jafari P., de Buys Roessingh A., Hirt-Burri N., Raffoul W., Applegate L.A., 2016/06/30. Annals of burns and fire disasters, 29 (2) pp. 111-115.
[URN][Pmid][serval:BIB_858E3C77D1F3]
 
Peptide-decorated chitosan derivatives enhance fibroblast adhesion and proliferation in wound healing.
Patrulea V., Hirt-Burri N., Jeannerat A., Applegate L.A., Ostafe V., Jordan O., Borchard G., 2016. Carbohydrate Polymers, 142 pp. 114-123. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_25BC7D7B2CB9]
2014
 
Biologie osseuse et cartilagineuse
Hirt-Burri N., Applegate L.A., 2014. pp. 71-78 dans Jolles-Haeberli B. (eds.) Manuel Pratique de Chirurgie Orthopédique chap. 3, Elsevier Masson.
[serval:BIB_7BA522738C4D]
Cell therapies for tendons: old cell choice for modern innovation.
Petrou I.G., Grognuz A., Hirt-Burri N., Raffoul W., Applegate L.A., 2014. Swiss Medical Weekly, 144 pp. w13989. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E3001FD2890]
 
How important is hydrotherapy? Effects of dynamic action of hot spring water as a rehabilitative treatment for burn patients in Switzerland
Moufarrij S., Deghayli L., Raffoul W., Hirt-Burri N., Michetti M., de Buys Roessingh A., Norberg M., Applegate L.A., 2014. Annals of Burns and Fire Disasters, 27 (4) pp. 184-191.
[Pmid][serval:BIB_9C3FC4843A6B]
 
Insurance coverage of pediatric burns: Switzerland versus USA.
Deghayli L., Moufarrij S., Norberg M., Sheridan R., Raffoul W., de Buys Roessingh A., Hirt-Burri N., Applegate L.A., 2014. Burns, 40 (5) pp. 814-825.
[DOI][WoS][Pmid][serval:BIB_F6D18A1D24E9]
2013
Cell Therapy Assistance in Reconstructive Surgery for Musculoskeletal Tissues Following Burn and Trauma: Swiss Cellular Transplantation Platform
De Buys Roessingh A., Guerid S, Que Y.A., Berger M., Hirt-Burri N., Scaletta C., Wassim R., Applegate L.A., 2013. Journal of Defense Management, 1 (S3) pp. 1-7.
[URN][DOI][serval:BIB_30978A694722]
 
Fetal Cell Therapy and Tissue Engineering for Musculoskeletal Tissues
Hirt-Burri N., Applegate L.A., 2013. pp. 185-192 dans Bhattacharya N., Stubblefield P. (eds.) Human Fetal Tissue Transplantation chap. 14, Springer.
[DOI][serval:BIB_E829AB7DE7EC]
 
Organ Donation and Whole-Cell Bioprocessing in the Swiss Fetal Progenitor Cell Transplantation Platform
Applegate L.A., Weber D., Simon J.P., Hirt-Burri N., De Buys Roessingh A., Raffoul W., 2013. pp. 125-148 dans Saidi R.F. (eds.) Organ Donation and Organ Donors: Issues, Challenges and Perspectives, Nova Publications.
[serval:BIB_EC92867DBFC4]
2012
Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing.
Akhundov K., Pietramaggiori G., Waselle L., Darwiche S., Guerid S., Scaletta C., Hirt-Burri N., Applegate L.A., Raffoul W.V., 2012. Annals of Burns and Fire Disasters, 25 (4) pp. 207-213.
[URN][Pmid][serval:BIB_51F00C216917]
2011
Biologicals and fetal cell therapy for wound and scar management.
Hirt-Burri N., Ramelet A.A., Raffoul W., de Buys Roessingh A., Scaletta C., Pioletti D., Applegate L.A., 2011. ISRN Dermatology, 2011 (549870) p. 549870.
[URN][DOI][Pmid][serval:BIB_77EF7158544C]
 
Human fetal bone cells in delivery systems for bone engineering.
Tenorio D.M., Scaletta C., Jaccoud S., Hirt-Burri N., Pioletti D.P., Jaques B., Applegate L.A., 2011. Journal of Tissue Engineering and Regenerative Medicine, 5 (10) pp. 806-14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB9A750AFDF3]
2009
 
Bioengineering of Human Fetal Tissues For Clinical Use
Applegate L.A., Hirt-Burri N., Scaletta C., Bauren J.-F., Pioletti D.P., 2009. pp. 133-152 dans Garcia Audric, Durand Ciel (eds.) Bioengineering: Principles, Methodologies and Applications chap. 4, Nova Science Publisher's.
[serval:BIB_0ED4915CE834]
 
Chronic wound healing by fetal cell therapy may be explained by differential gene profiling observed in fetal versus old skin cells.
Ramelet A.A., Hirt-Burri N., Raffoul W., Scaletta C., Pioletti D.P., Offord E., Mansourian R., Applegate L.A., 2009. Experimental Gerontology, 44 (3) pp. 208-18. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B7B09D71C1A]
 
Whole-cell bioprocessing of human fetal cells for tissue engineering of skin.
Applegate L.A., Scaletta C., Hirt-Burri N., Raffoul W., Pioletti D., 2009. Skin Pharmacology and Physiology, 22 (2) pp. 63-73.
[DOI][WoS][Pmid][serval:BIB_9580C614BF48]
2008
Human muscular fetal cells: a potential cell source for muscular therapies.
Hirt-Burri N., de Buys Roessingh A.S., Scaletta C., Gerber S., Pioletti D.P., Applegate L.A., Hohlfeld J., 2008. Pediatric Surgery International, 24 (1) pp. 37-47.
[URN][DOI][WoS][Pmid][serval:BIB_92F32F8A6D9C]
 
Wound-healing gene family expression differences between fetal and foreskin cells used for bioengineered skin substitutes.
Hirt-Burri N., Scaletta C., Gerber S., Pioletti D.P., Applegate L.A., 2008. Artificial Organs, 32 (7) pp. 509-518. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC42C6BFDF44]
2007
Consistency and safety of cell banks for research and clinical use: preliminary analysis of fetal skin banks.
Quintin A., Hirt-Burri N., Scaletta C., Schizas C., Pioletti D.P., Applegate L.A., 2007. Cell Transplantation, 16 (7) pp. 675-684.
[URN][WoS][Pmid][serval:BIB_BF5486739CC0]
Water-filtered infrared-A radiation (wIRA) is not implicated in cellular degeneration of human skin.
Gebbers N., Hirt-Burri N., Scaletta C., Hoffmann G., Applegate L.A., 2007. German Medical Science : Gms E-journal, 5 pp. Doc08.
[URN][WoS][Pmid][serval:BIB_E6DF6AF5B2E9]
2006
Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing.
De Buys Roessingh A.S., Hohlfeld J., Scaletta C., Hirt-Burri N., Gerber S., Hohlfeld P., Gebbers J.O., Applegate L.A., 2006. Cell Transplantation, 15 (8-9) pp. 823-834.
[URN][WoS][Pmid][serval:BIB_8FD0E016D20B]
2005
 
Tissue engineered fetal skin constructs for paediatric burns.
Hohlfeld J., de Buys Roessingh A., Hirt-Burri N., Chaubert P., Gerber S., Scaletta C., Hohlfeld P., Applegate L.A., 2005. Lancet, 366 (9488) pp. 840-842. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9BC5BEC0CB5]
2004
 
Fetal bone cells for tissue engineering.
Montjovent M.O., Burri N., Mark S., Federici E., Scaletta C., Zambelli P.Y., Hohlfeld P., Leyvraz P.F., Applegate L.L., Pioletti D.P., 2004. Bone, 35 (6) pp. 1323-1333.
[DOI][WoS][Pmid][serval:BIB_91E870B2A46E]
2001
 
Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer
Burri N., Shaw P., Bouzourene H., Sordat I., Sordat B., Gillet M., Schorderet D., Bosman F. T., Chaubert P., 2001/02. Laboratory Investigation, 81 (2) pp. 217-29.
[WoS][Pmid][serval:BIB_53298DE57BAD]
 
A novel highly informative polyA microsatellite on the telomeric side of the INK4a/ARF locus
Chaubert P., Burri N., Cousin P., Shaw P., 2001. Molecular and Cellular Probes, 15 (3) pp. 183-185.
[DOI][WoS][Pmid][serval:BIB_BDB1D4B729F8]
1999
 
Complex methylation patterns analyzed by single-strand conformation polymorphism
Burri N., Chaubert P., 1999. BioTechniques, 26 (2) pp. 232-234.
[WoS][Pmid][serval:BIB_EC08471872DF]
 
Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas
Baur A. S., Shaw P., Burri N., Delacretaz F., Bosman F. T., Chaubert P., 1999. Blood, 94 (5) pp. 1773-1781.
[WoS][Pmid][serval:BIB_17C1DC6ADA62]
1997
 
Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase
Huber M., Yee V. C., Burri N., Vikerfors E., Lavrijsen A. P., Paller A. S., Hohl D., 1997/08. Journal of Biological Chemistry, 272 (34) pp. 21018-26.
[DOI][WoS][Pmid][serval:BIB_C8992F452A4D]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University